| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achievement of ATP III Combined LDL-C and Non-HDL-C Goals of <100 and <130 mg/dL or <70 and <100 mg/dL with 3 Different Statins: Results from VOYAGER
|
Toth, Peter P.
|
|
2013
|
7 |
3 |
p. 284-285
2 p.
|
artikel
|
| 2 |
Alirocumab, a Fully Human Monoclonal Antibody to PCSK9, Reduces High Plasma Lp(a) Concentration: Pooled Analysis of 352 Patients from Phase 2
|
Gaudet, Daniel
|
|
2013
|
7 |
3 |
p. 283-284
2 p.
|
artikel
|
| 3 |
Alirocumab, a Fully Human Monoclonal Antibody to Proprotein Convertase Subtilisin/kexin Type 9: Therapeutic Dosing in Phase 3 Studies
|
Pordy, Robert
|
|
2013
|
7 |
3 |
p. 279-
1 p.
|
artikel
|
| 4 |
Analysis of Generic Simvastatin and Atorvastatin Versus Branded Rosuvastatin in Hyperlipidemic Patients: A Budget Impact Model from a U.S.-Managed Care Organization Perspective
|
Montouchet, Calypso
|
|
2013
|
7 |
3 |
p. 262-
1 p.
|
artikel
|
| 5 |
Apheresis Treatment did not Impact the Efficacy of Lomitapide in Patients with Homozygous Familial Hypercholesterolemia: Results from the Pivotal Phase†
|
Cuchel, Marina
|
|
2013
|
7 |
3 |
p. 286-287
2 p.
|
artikel
|
| 6 |
A randomized trial of coenzyme Q10 in patients with statin myopathy: Rationale and study design
|
Parker, Beth A.
|
|
2013
|
7 |
3 |
p. 187-193
7 p.
|
artikel
|
| 7 |
Atorvastatin Generics Obtained from Multiple Sources Worldwide Contain a Methylated Impurity that Reduces Their HMG-CoA Reductase Inhibitory Effects
|
Mason, Richard Preston
|
|
2013
|
7 |
3 |
p. 287-
1 p.
|
artikel
|
| 8 |
Challenges in Implementing an Interdisciplinary Cardiometabolic Risk Reduction Clinic†
|
Kirkpatrick, Carol
|
|
2013
|
7 |
3 |
p. 257-
1 p.
|
artikel
|
| 9 |
Comparing the Effectiveness of Atorvastatin and Rosuvastatin for Managing Elevated Cholesterol in Clinical Practice Settings: a Simulated Study†
|
van Herick, Andrew
|
|
2013
|
7 |
3 |
p. 261-
1 p.
|
artikel
|
| 10 |
Concordance and Discordance Between Apolipoprotein B, LDL-C and non-HDL-C in Subjects Presenting to the Emergency Room with Acute Coronary Syndrome*
|
Pitts, Reynaria N.
|
|
2013
|
7 |
3 |
p. 239-
1 p.
|
artikel
|
| 11 |
Counterpoint: Statins do reduce fatal events
|
Sniderman, Allan D.
|
|
2013
|
7 |
3 |
p. 225-227
3 p.
|
artikel
|
| 12 |
Discordance Between LDL Particle Number (LDL-P) and LDL-cholesterol (LDL-C) Among Patients Treated at Two Medical Systems
|
Uusinarkaus, Kari
|
|
2013
|
7 |
3 |
p. 239-240
2 p.
|
artikel
|
| 13 |
Discordance of Non-HDL and Directly Measured LDL Cholesterol: Which Lipid Measure is Preferred When Calculated LDL is Inaccurate?
|
Baruch, Lawrence
|
|
2013
|
7 |
3 |
p. 234-235
2 p.
|
artikel
|
| 14 |
Dyslipidemia Profile in Cholesteryl Ester Storage Disorder
|
Tripuraneni, Radhika
|
|
2013
|
7 |
3 |
p. 251-
1 p.
|
artikel
|
| 15 |
Editorial Board
|
|
|
2013
|
7 |
3 |
p. A1-A2
nvt p.
|
artikel
|
| 16 |
Effects of Ezetimibe, Ezetimibe Coadministered with Statins and Statin Therapies on Fasting Glucose Changes in Patients with Hypercholesterolemia
|
Toth, Peter P.
|
|
2013
|
7 |
3 |
p. 277-278
2 p.
|
artikel
|
| 17 |
Effects of Icosapent Ethyl on Lipoprotein Particle Concentration and the Fatty Acid Desaturation Index in Statin-treated Patients With Persistent High Triglycerides (the ANCHOR Study)
|
Ballantyne, Christie M.
|
|
2013
|
7 |
3 |
p. 270-271
2 p.
|
artikel
|
| 18 |
Effects of Prescription Omega-3-Acid Ethyl Esters on Fasting and Postprandial Lipoprotein Subclass Cholesterol Concentrations
|
Maki, Kevin Carl
|
|
2013
|
7 |
3 |
p. 268-269
2 p.
|
artikel
|
| 19 |
Effects on Cholesterol Levels and Attainment of NCEP LDL-C Goals in Statin Intolerant Patients Referred to a Lipid Clinic*
|
Hirai, Taishi
|
|
2013
|
7 |
3 |
p. 265-266
2 p.
|
artikel
|
| 20 |
Efficacy and Safety of AMG 145, a Fully Human Monoclonal Antibody to PCSK9: Data from Four Phase 2 Studies in Over 1200 Patients
|
Raal, Frederick
|
|
2013
|
7 |
3 |
p. 278-
1 p.
|
artikel
|
| 21 |
Efficacy and Safety of Ezetimibe Monotherapy in 6-10 Year Old Children with Heterozygous Familial or Non-familial Hypercholesterolemia
|
Gagné, Claude
|
|
2013
|
7 |
3 |
p. 257-258
2 p.
|
artikel
|
| 22 |
Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized double-blind (ORD) study
|
Tatsuno, Ichiro
|
|
2013
|
7 |
3 |
p. 199-207
9 p.
|
artikel
|
| 23 |
Efficacy, Safety and Tolerability of Alirocumab 150 mg Q2W, a Fully Human PCSK9 Monoclonal Antibody: A Pooled Analysis of 352 Patients from Phase 2
|
Koren, Michael Joseph
|
|
2013
|
7 |
3 |
p. 279-280
2 p.
|
artikel
|
| 24 |
Eicosapentaenoic Acid (EPA) Inhibits the Formation of Membrane Cholesterol Crystalline Domains by a Potent Antioxidant Mechanism
|
Mason, Richard Preston
|
|
2013
|
7 |
3 |
p. 272-273
2 p.
|
artikel
|
| 25 |
Epanova Lowers Apolipoprotein C-III and Increases LDL-Particle Size in Statin-Treated Patients With Mild Hypertriglyceridemia
|
Maki, Kevin Carl
|
|
2013
|
7 |
3 |
p. 269-
1 p.
|
artikel
|
| 26 |
ETC-1002 Lowers LDL-Cholesterol and Beneficially Modulates Other Cardio-Metabolic Risk Factors in Hypercholesterolemic Subjects†
|
Rosenberg, Noah
|
|
2013
|
7 |
3 |
p. 283-
1 p.
|
artikel
|
| 27 |
ETC-1002 Rapidly and Significantly Reduces LDL-Cholesterol and is Well Tolerated in Healthy Subjects†
|
Rosenberg, Noah
|
|
2013
|
7 |
3 |
p. 280-281
2 p.
|
artikel
|
| 28 |
ETC-1002 Reduces LDL-Cholesterol and Beneficially Modulates Additional Cardio-Metabolic Risk Factors in Subjects with Type 2 Diabetes†
|
Rosenberg, Noah
|
|
2013
|
7 |
3 |
p. 282-283
2 p.
|
artikel
|
| 29 |
Evaluation of Lipids in Children with Type 1 Diabetes Mellitus Compared to Controls
|
Al-Rasadi, Khalid Humaid
|
|
2013
|
7 |
3 |
p. 243-244
2 p.
|
artikel
|
| 30 |
Ezetimibe & Atorvastatin Coadministration vs Atorvastatin Uptitration or Switching to Rosuvastatin in Primary Hypercholesterolemic Patients at High Cardiovascular Risk
|
Bays, Harold E.
|
|
2013
|
7 |
3 |
p. 280-
1 p.
|
artikel
|
| 31 |
Familial Hypercholesterolemia in a Large Ambulatory Population: Use of the Electronic Record and Relationship to Clinical Disease
|
Knickelbine, Thomas
|
|
2013
|
7 |
3 |
p. 255-256
2 p.
|
artikel
|
| 32 |
Familial Hypobetalipoproteinemia and Mental Retardation
|
Simha, A.J. Vinaya
|
|
2013
|
7 |
3 |
p. 250-251
2 p.
|
artikel
|
| 33 |
From the Editor: NLA Scientific Sessions
|
Brown, W. Virgil
|
|
2013
|
7 |
3 |
p. 185-
1 p.
|
artikel
|
| 34 |
HDL Particle Number in Patients with Angiographic Coronary Artery Disease on Lipid-Lowering Medication
|
Malave, Hector
|
|
2013
|
7 |
3 |
p. 236-
1 p.
|
artikel
|
| 35 |
Heterogeneity of LDL and HDL Particle Concentrations in Subjects Meeting LDL-Cholesterol Goals
|
Underberg, James
|
|
2013
|
7 |
3 |
p. 235-236
2 p.
|
artikel
|
| 36 |
High Prevalence of Elevated Coronary Artery Calcium Deposition in Patients with Heterozygous Familial Hypercholesterolemia Despite Long-Term Aggressive LDL Lowering for More Than 15 Years
|
Duell, P. Barton
|
|
2013
|
7 |
3 |
p. 258-
1 p.
|
artikel
|
| 37 |
High Proportion of Discordance between ApoB and LDL-P in Clinical Practice is Associated with Insulin Resistance in More than 80,000 Individuals
|
Dayspring, Thomas D.
|
|
2013
|
7 |
3 |
p. 241-242
2 p.
|
artikel
|
| 38 |
Hypothyroidism as a Risk Factor for Statin Intolerance*
|
Robison, Craig D.
|
|
2013
|
7 |
3 |
p. 266-267
2 p.
|
artikel
|
| 39 |
Identifying Cases of Cholesteryl Ester Storage Disease in a Tertiary Lipid Clinic
|
Kane, John P.
|
|
2013
|
7 |
3 |
p. 249-
1 p.
|
artikel
|
| 40 |
Impact of Inflammatory Biomarkers on Relation of HDL-C with Incident Coronary Heart Disease and Cardiovascular Disease: Cardiovascular Health Study*
|
Tehrani, David
|
|
2013
|
7 |
3 |
p. 251-253
3 p.
|
artikel
|
| 41 |
Impact of Obesity and Healthy Eating Index on Coronary Heart Disease, Stroke, and Cardiovascular Disease Mortality in United States Adults*
|
Patel, Rohini J.
|
|
2013
|
7 |
3 |
p. 248-249
2 p.
|
artikel
|
| 42 |
Impact of Superstorm Sandy on the Lipid Panel of a Patient with Familial Hypercholesterolemia*
|
Greet, Brian
|
|
2013
|
7 |
3 |
p. 245-
1 p.
|
artikel
|
| 43 |
Implementation of Pediatric Lipid Screening Guidelines Among Primary Pediatric Providers*
|
Dixon, Damon Brian
|
|
2013
|
7 |
3 |
p. 261-262
2 p.
|
artikel
|
| 44 |
Increased β-cell Proliferation and β-cell Mass Induced Through High Fat Diet in Mice*
|
Arasi, Kavin
|
|
2013
|
7 |
3 |
p. 244-
1 p.
|
artikel
|
| 45 |
Incremental Benefit of Adherence in a Community-based Weight Loss Program
|
Johnston, Craig A.
|
|
2013
|
7 |
3 |
p. 244-
1 p.
|
artikel
|
| 46 |
Investigation of Pitavastatin-associated Muscular and Renal Adverse Events Compared to Other Statins: Cases from the Food and Drug Administration Adverse Event Reporting System Database
|
Gandhi, Pranav K.
|
|
2013
|
7 |
3 |
p. 255-
1 p.
|
artikel
|
| 47 |
Lack of Drug-Drug Interaction between Mipomersen and Warfarin in Healthy Volunteers
|
Li, Zhaoyang
|
|
2013
|
7 |
3 |
p. 276-277
2 p.
|
artikel
|
| 48 |
Lipid Abnormalities in Foreign and US-Born Patients in a Medical Group
|
Jaranilla, Jawali
|
|
2013
|
7 |
3 |
p. 258-259
2 p.
|
artikel
|
| 49 |
Lipoprotein Lipase Deficiency Clinical Biomarkers*
|
Dubois-Bouchard, Camélia
|
|
2013
|
7 |
3 |
p. 241-
1 p.
|
artikel
|
| 50 |
Lipoprotein Particle Number (LDL-P) Distribution in Polycystic Ovary Syndrome Patients
|
Reingold, Jason
|
|
2013
|
7 |
3 |
p. 238-239
2 p.
|
artikel
|
| 51 |
Long Term Efficacy and Safety of Mipomersen During 4 Years of Treatment in a Cohort of Patients with Heterozygous Familial Hypercholesterolemia and Coronary Artery Disease (CAD)
|
Duell, P. Bart
|
|
2013
|
7 |
3 |
p. 276-
1 p.
|
artikel
|
| 52 |
Long Term Tolerance of Pitavastatin in Patients with Prior Statin Intolerance*
|
Chau, Quynh An
|
|
2013
|
7 |
3 |
p. 264-
1 p.
|
artikel
|
| 53 |
Low HDL is an Independent Risk Factor for Athero and Venous Thrombotic Events
|
Baykal, Demir
|
|
2013
|
7 |
3 |
p. 254-
1 p.
|
artikel
|
| 54 |
Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol
|
Juren, Andrew J.
|
|
2013
|
7 |
3 |
p. 194-198
5 p.
|
artikel
|
| 55 |
Management of Aminotransferase Elevations Observed in a Phase 3 Study of Patients with Homozygous Familial Hypercholesterolemia Treated with Lomitapide
|
Cuchel, Marina
|
|
2013
|
7 |
3 |
p. 263-264
2 p.
|
artikel
|
| 56 |
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum
|
Rynkiewicz, Andrzej
|
|
2013
|
7 |
3 |
p. 217-221
5 p.
|
artikel
|
| 57 |
Management of Hypercholesterolemia Utilizing a Home Lipid Monitoring System: Preliminary Findings*
|
Alkhouli, Mohamad A.
|
|
2013
|
7 |
3 |
p. 254-255
2 p.
|
artikel
|
| 58 |
Management of Severe Hypertriglyceridemia with a Novel Omega-3 Free- Fatty Acid Formulation: Subgroups in the EVOLVE Trial
|
Kastelein, John J.P.
|
|
2013
|
7 |
3 |
p. 271-272
2 p.
|
artikel
|
| 59 |
New-onset hypercholesterolemia as an unusual presenting manifestation of eosinophilic gastroenteritis
|
Gonnelli, Stefano
|
|
2013
|
7 |
3 |
p. 229-233
5 p.
|
artikel
|
| 60 |
News from the NLA
|
|
|
2013
|
7 |
3 |
p. 186-
1 p.
|
artikel
|
| 61 |
Non-communicable Disease Risk Factors in Pediatric Double Burden Populations*
|
Sergent, Shane Ryan
|
|
2013
|
7 |
3 |
p. 288-
1 p.
|
artikel
|
| 62 |
Novel Biomarkers for the Prediction of Acute Coronary Syndrome*
|
Gonzales, Kristen
|
|
2013
|
7 |
3 |
p. 246-247
2 p.
|
artikel
|
| 63 |
Novel Revelations in Familial Hypercholesterolemia*
|
Banerjee, Yajnavalka
|
|
2013
|
7 |
3 |
p. 250-
1 p.
|
artikel
|
| 64 |
Omega-3 Fatty Acids Supplementation to Pregnant Women and Birth Anthropometric Parameters of Their Newborns*
|
Hajduk, Magdalena
|
|
2013
|
7 |
3 |
p. 272-
1 p.
|
artikel
|
| 65 |
Oral Contraceptives: A Cause of Elevated LDL-Particle Number in Two Young Dyslipidemic Women*
|
Chiu, Kathleen M.
|
|
2013
|
7 |
3 |
p. 263-
1 p.
|
artikel
|
| 66 |
Oxidized high-density Lipoprotein in Obese Adolescents*
|
Marin, Monica T.
|
|
2013
|
7 |
3 |
p. 275-276
2 p.
|
artikel
|
| 67 |
Pharmacological Actions of Niacin on Human Blood Leukocyte Myeloperoxidase (MPO) and MPO-mediated Formation of Dysfunctional HDL
|
Kamanna, Vaijinath (Vijay)
|
|
2013
|
7 |
3 |
p. 253-
1 p.
|
artikel
|
| 68 |
Phase 1 Study of the Effect of Icosapent Ethyl on Atorvastatin Pharmacokinetics in Healthy Subjects
|
Braeckman, Rene
|
|
2013
|
7 |
3 |
p. 269-270
2 p.
|
artikel
|
| 69 |
Phase 1 Study of the Effect of Icosapent Ethyl on Warfarin Pharmacokinetics and Anticoagulation Pharmacodynamics in Healthy Subjects
|
Braeckman, Rene
|
|
2013
|
7 |
3 |
p. 270-
1 p.
|
artikel
|
| 70 |
Physician-Prompts in an Electronic Medical Record Improve Secondary Prevention Best Practices for Risk Factor Targets, Medication Use and Reduce Utilization and Costs
|
Sheikh, Khalid Hasan
|
|
2013
|
7 |
3 |
p. 256-257
2 p.
|
artikel
|
| 71 |
Pitavastatin 4 mg Provides Superior LDL-C Reduction vs. Pravastatin 40 mg Over 12 weeks in HIV-Infected Adults with Dyslipidemia, the INTREPID Trial
|
Sponseller, Craig A.
|
|
2013
|
7 |
3 |
p. 260-
1 p.
|
artikel
|
| 72 |
Plasma Omega-3 Fatty Acid Distribution in a U.S. Population
|
Superko, H. Robert
|
|
2013
|
7 |
3 |
p. 268-
1 p.
|
artikel
|
| 73 |
Point: Why statins have failed to reduce mortality in just about anybody
|
Vos, Eddie
|
|
2013
|
7 |
3 |
p. 222-224
3 p.
|
artikel
|
| 74 |
Predictors of Statin Adherence, Switching, and Discontinuation in the USAGE Survey: Understanding Statin Use in America and Gaps in Patient Education*
|
Wei, Melissa Y.
|
|
2013
|
7 |
3 |
p. 245-246
2 p.
|
artikel
|
| 75 |
Prevalence of Unrecognized Diabetes, Prediabetes and Metabolic Syndrome in Patients Referred for Non-Urgent Percutaneous Intervention*
|
Balakrishnan, Revathi
|
|
2013
|
7 |
3 |
p. 242-243
2 p.
|
artikel
|
| 76 |
Real World Lipid Control for Secondary Prevention of CAD in Patients Undergoing Repeat Percutaneous Coronary Intervention*
|
Rajamanickam, Anitha
|
|
2013
|
7 |
3 |
p. 259-260
2 p.
|
artikel
|
| 77 |
Rebuttal: Why statins have failed to reduce mortality in just about anybody
|
Vos, Eddie
|
|
2013
|
7 |
3 |
p. 228-
1 p.
|
artikel
|
| 78 |
Red Yeast Rice Supplements in Lowering LDL-C: A Meta-analysis*
|
Casciola, Alan Thomas
|
|
2013
|
7 |
3 |
p. 264-265
2 p.
|
artikel
|
| 79 |
Relationship among low cholesterol levels, depressive symptoms, aggression, hostility, and cynicism
|
Sahebzamani, Frances M.
|
|
2013
|
7 |
3 |
p. 208-216
9 p.
|
artikel
|
| 80 |
Residual Risk: A Case of a Patient at LDL-C Goal on Statin Therapy but with Significant Cardiovascular Disease*
|
Sowa, Alexandra
|
|
2013
|
7 |
3 |
p. 238-
1 p.
|
artikel
|
| 81 |
Right-Sided Congestive Heart Failure: A Perplexing Etiology of Hyperammonemic Encephalopathy∗
|
Haider, Muhammad A.
|
|
2013
|
7 |
3 |
p. 248-
1 p.
|
artikel
|
| 82 |
Rise in Serum Lipids After Dietary Incorporation of Coconut Fats*
|
Singh, Amita
|
|
2013
|
7 |
3 |
p. 267-
1 p.
|
artikel
|
| 83 |
Sebelipase Alfa Improves Dyslipidemia in Patients with Cholesteryl Ester Storage Disease
|
Tripuraneni, Radhika
|
|
2013
|
7 |
3 |
p. 286-
1 p.
|
artikel
|
| 84 |
Severe Hypertriglyceridemia and Recurrent Pancreatitis In a Patient With SLE and an Underlying Mutation in the Lipase Maturation Factor-1 Gene*
|
Singh, Amita
|
|
2013
|
7 |
3 |
p. 249-250
2 p.
|
artikel
|
| 85 |
Severe Hypertriglyceridemia Secondary to Antiretroviral Drugs in an Adolescent with Hereditary Pancreatitis*
|
Chan, Albert
|
|
2013
|
7 |
3 |
p. 262-263
2 p.
|
artikel
|
| 86 |
Statin Intolerance Can be Monitored by Plasma Eicosanoid Assays
|
Laaksonen, Reijo
|
|
2013
|
7 |
3 |
p. 265-
1 p.
|
artikel
|
| 87 |
Suboptimal LDL-C Lowering in High-risk Patients with Coronary Heart Disease or Atherosclerotic Vascular Disease in the U.S.
|
Marrett, Elizabeth
|
|
2013
|
7 |
3 |
p. 247-248
2 p.
|
artikel
|
| 88 |
Table of Contents
|
|
|
2013
|
7 |
3 |
p. A3-A4
nvt p.
|
artikel
|
| 89 |
The ACT II Study: Influence of BMI on Serum Lipids
|
Lautsch, Dominik
|
|
2013
|
7 |
3 |
p. 287-288
2 p.
|
artikel
|
| 90 |
The DGAT1 inhibitor Pradigastat Decreases Chylomicron Secretion and Prevents Postprandial Triglyceride Elevation in Humans
|
Meyers, Charles Daniel
|
|
2013
|
7 |
3 |
p. 285-
1 p.
|
artikel
|
| 91 |
The Effect of High Dose Insulin Analog Initiation Therapy on LDL/HDL Subfraction Profile and HDL Associated Enzymes in Type 2 Diabetic Patients
|
Aslan, Ibrahim
|
|
2013
|
7 |
3 |
p. 242-
1 p.
|
artikel
|
| 92 |
The Effects of One Avocado Per Day on Small, Dense LDL and the Relationship of TG, VLDL, HDL, ApoB, and ApoB/A1 with LDL Particle Size*
|
Wang, Li
|
|
2013
|
7 |
3 |
p. 267-268
2 p.
|
artikel
|
| 93 |
The Lipid Regulatory Hypothesis I
|
Feeman Jr., W.E.
|
|
2013
|
7 |
3 |
p. 273-
1 p.
|
artikel
|
| 94 |
The Lipid Regulatory Hypothesis II
|
Feeman Jr., W.E.
|
|
2013
|
7 |
3 |
p. 273-274
2 p.
|
artikel
|
| 95 |
The Lipid Regulatory Hypothesis III
|
Feeman Jr., W.E.
|
|
2013
|
7 |
3 |
p. 274-275
2 p.
|
artikel
|
| 96 |
Utilization of Advanced Lipoprotein Testing in an Academic Cardiology Practice*
|
Duffy, Danielle
|
|
2013
|
7 |
3 |
p. 236-237
2 p.
|
artikel
|
| 97 |
Validation of Lp(a) Particle Number Analysis by Quantitative Lipo-IFE
|
Guadagno, Phil
|
|
2013
|
7 |
3 |
p. 240-241
2 p.
|
artikel
|
| 98 |
Variability of the LDL-C Lowering Response to Ezetimibe and Ezetimibe + Statin Therapy in Hypercholesterolemic Patients
|
Tomassini, Joanne E.
|
|
2013
|
7 |
3 |
p. 281-282
2 p.
|
artikel
|
| 99 |
Walk it Wear it, Promoting a Healthy Lifestyle†
|
Neri, Lori M.
|
|
2013
|
7 |
3 |
p. 275-
1 p.
|
artikel
|
Tijdschrift beschrijving